VVOS (Vivos Therapeutics) Days Payable : 61.93 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Vivos Therapeutics Days Payable?

Vivos Therapeutics's average Accounts Payable for the three months ended in Dec. 2024 was $1.09 Mil. Vivos Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2024 was $1.60 Mil. Hence, Vivos Therapeutics's Days Payable for the three months ended in Dec. 2024 was 61.93.

The historical rank and industry rank for Vivos Therapeutics's Days Payable or its related term are showing as below:

VVOS' s Days Payable Range Over the Past 10 Years
Min: 70.84 Med: 103.86 Max: 160.05
Current: 107.4

During the past 7 years, Vivos Therapeutics's highest Days Payable was 160.05. The lowest was 70.84. And the median was 103.86.

VVOS's Days Payable is ranked better than
67.38% of 791 companies
in the Medical Devices & Instruments industry
Industry Median: 69.21 vs VVOS: 107.40

Vivos Therapeutics's Days Payable declined from Dec. 2023 (144.59) to Dec. 2024 (61.93). It may suggest that Vivos Therapeutics accelerated paying its suppliers.

Vivos Therapeutics Days Payable Historical Data

The historical data trend for Vivos Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivos Therapeutics Days Payable Chart

Vivos Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

128.22

72.51

70.84

117.35

98.44

Vivos Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															144.59	142.97	147.22	92.77	61.93

Competitive Comparison of Vivos Therapeutics's Days Payable

For the Medical Devices subindustry, Vivos Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivos Therapeutics's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vivos Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Vivos Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Vivos Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vivos Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (2.145	+	1.098)	/	2 )	/	6.012	*	365
=	1.6215					/	6.012	*	365
=	98.44

Vivos Therapeutics's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (1.075	+	1.098)	/	2 )	/	1.601	*	365 / 4
=	1.0865					/	1.601	*	365 / 4
=	61.93

Vivos Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Vivos Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivos Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vivos Therapeutics Inc (NAS:VVOS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7921 Southpark Plaza, Suite 210, Littleton, CO, USA, 80120

Website

https://www.vivos.com

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Executives

Ronald Kirk Huntsman	director, 10 percent owner, officer: Chairman & CEO	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Bradford K. Amman	officer: Chief Financial Officer	6400 S. FIDDLER'S GREEN CIRCLE, SUITE 1970, GREENWOOD VILLAGE X1 80111
Leonard J Sokolow	director	REGATTA OFFICE PARK, WINDWARD THREE, 4TH FLOOR, WEST BAY ROAD, P.O. BOX 1114, GRAND CAYMAN E9 E9 KY11102
Matthew Thompson	director	2 MUSICK, IRVINE CA 92618
Anja B Krammer	director	C/O BIOPHARMX CORPORATION, 1505 ADAMS DRIVE, SUITE D, MENLO PARK CA 94025
Gurdev Dave Singh	director, 10 percent owner, officer: Chief Medical Officer	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Mark F. Lindsay	director	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129
Ralph Elias Green	director	9137 RIDGELINE BOULEVARD, SUITE 135, HIGHLANDS RANCH CO 80129